Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
NMD Pharma - Capnova
NMD Pharma A/S | LinkedIn
NMD Pharma breder sig til nye områder før næste kapitalrejsning
NMD Pharma begins first clinical trial: "Our entire team can be enormously proud"
NMD Pharma
NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn
UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Argenx køber amerikansk guldkupon til middel, som NMD Pharma skal konkurrere mod
Detailed Description | NMD-GPS
Nmd Pharma A/S, Aarhus N | firma | krak.dk
Thomas H. Pedersen - CEO at NMD Pharma | The Org
NMD Pharma | The Lundbeck Foundation
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670 | Lifecarenews
Tagged with NMDPharma - EY Danmark
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
Roel Bulthuis - Director at NMD Pharma | The Org
NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn
NMD Pharma company information, funding & investors | Dealroom.co
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
NMD Pharma A/S | LinkedIn
NMD PHARMA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
